The Rotterdam Eye Hospital/Rotterdam Ophthalmic Institute, Rotterdam, the Netherlands.
Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
Acta Ophthalmol. 2018 Mar;96(2):192-196. doi: 10.1111/aos.13560. Epub 2017 Oct 25.
As some surgical procedures have been shown to increase postoperative flare values and thus contribute to blood-ocular barrier breakdown, retinal reattachment surgery might influence the risk of developing proliferative vitreoretinopathy (PVR). Therefore, we investigated whether postoperative aqueous flare values are a surrogate marker for the development of postoperative PVR.
We prospectively included 195 patients with primary rhegmatogenous retinal detachment (RRD) and measured aqueous laser flare preoperatively, and at 2 and 6 weeks postoperatively. Postoperative PVR was defined as reoperation for redetachment due to PVR membranes, within 6 months of initial surgery. Logistic regression and receiver operating characteristic (ROC) analysis determined whether higher postoperative flare values were associated with an increased risk of developing PVR later on.
Reoperation for postoperative PVR was needed in 12 (6.2%) patients; in 18 (9.2%), reoperation was not related to PVR. The median flare value for patients who would develop PVR was significantly higher than that of patients who would not develop PVR, both at 2 weeks (p = 0.001) and 6 weeks (p < 0.001) postoperatively. Logistic regression analyses showed that a higher flare value significantly increased the odds of developing PVR, either at 2 weeks [odds ratio (OR) 1.027; 95% CI: 1.010-1.044] or 6 weeks (OR 1.076; 95% CI: 1.038-1.115).
Flare values both at 2 and 6 weeks postoperatively seem a good surrogate marker in terms of sensitivity and specificity for the development of postoperative PVR but have only a modest positive predictive value. The 2-week value would be more useful in terms of early recognition of high-risk patients and hence give the possibility to better study effects of treatment methods.
由于一些手术已被证明会增加术后闪辉值,从而导致血眼屏障破裂,视网膜复位手术可能会影响发生增生性玻璃体视网膜病变(PVR)的风险。因此,我们研究了术后房水闪辉值是否是术后发生 PVR 的替代标志物。
我们前瞻性纳入 195 例原发性孔源性视网膜脱离(RRD)患者,分别在术前和术后 2 周及 6 周时测量房水激光闪辉值。术后 PVR 定义为初次手术后 6 个月内因 PVR 膜而再次手术以重新脱离。采用逻辑回归和受试者工作特征(ROC)分析确定术后较高的闪辉值是否与以后发生 PVR 的风险增加有关。
12 例(6.2%)患者需要因术后 PVR 而再次手术;18 例(9.2%)患者再次手术与 PVR 无关。发生 PVR 的患者的中位闪辉值明显高于未发生 PVR 的患者,术后 2 周时(p=0.001)和 6 周时(p<0.001)均如此。逻辑回归分析显示,较高的闪辉值显著增加了发生 PVR 的几率,术后 2 周时(比值比 [OR] 1.027;95%置信区间:1.010-1.044)和 6 周时(OR 1.076;95%置信区间:1.038-1.115)均如此。
术后 2 周和 6 周的闪辉值在预测术后 PVR 的敏感性和特异性方面似乎都是很好的替代标志物,但阳性预测值仅为中等。就早期识别高危患者而言,2 周时的数值可能更有用,从而有机会更好地研究治疗方法的效果。